A comparative study of Phyllanthus amarus compound and interferon in the treatment of chronic viral hepatitis B. 2001

W Xin-Hua, and L Chang-Qing, and G Xing-Bo, and F Lin-Chun
Tropical Medicine Institute, Guangzhou University of Traditional Chinese Medicine, Guangdong, People's Republic of China.

Fifty-five patients with chronic viral hepatitis B were randomly divided into two groups. Thirty patients were treated with Phyllanthus amarus compound (PA Co) for three months in the treatment group, another 25 patients were treated with domestic recombinant human interferon alpha-1b (IFN-alpha 1b) for three months as controls. The total effective rate in the treatment group was 83.3%, showing no significant difference from the control (p>0.05). The normalization rates of ALT, A/G and SB in the treatment group were 73.3%, 80.0% and 78.2% respectively, which were significantly higher than that in the control (p<0.05). The negative conversion rates of HBeAg and HBV-DNA in the treatment group were 42.3% and 47.8%, showing no significant difference from the control (p>0.005). It is indicated that PA Co has remarkable effect for chronic viral hepatitis B in recovery of liver function and inhibition of the replication of HBV.

UI MeSH Term Description Entries
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008297 Male Males
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon
D019694 Hepatitis B, Chronic INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Chronic Hepatitis B,Chronic Hepatitis B Virus Infection,Hepatitis B Virus Infection, Chronic

Related Publications

W Xin-Hua, and L Chang-Qing, and G Xing-Bo, and F Lin-Chun
October 1990, Lancet (London, England),
W Xin-Hua, and L Chang-Qing, and G Xing-Bo, and F Lin-Chun
January 1999, Tropical gastroenterology : official journal of the Digestive Diseases Foundation,
W Xin-Hua, and L Chang-Qing, and G Xing-Bo, and F Lin-Chun
October 1988, Lancet (London, England),
W Xin-Hua, and L Chang-Qing, and G Xing-Bo, and F Lin-Chun
October 1988, Lancet (London, England),
W Xin-Hua, and L Chang-Qing, and G Xing-Bo, and F Lin-Chun
May 1991, Journal of hepatology,
W Xin-Hua, and L Chang-Qing, and G Xing-Bo, and F Lin-Chun
September 1991, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
W Xin-Hua, and L Chang-Qing, and G Xing-Bo, and F Lin-Chun
March 1991, The Indian journal of medical research,
W Xin-Hua, and L Chang-Qing, and G Xing-Bo, and F Lin-Chun
January 1989, Cancer detection and prevention,
W Xin-Hua, and L Chang-Qing, and G Xing-Bo, and F Lin-Chun
March 1990, Vaccine,
W Xin-Hua, and L Chang-Qing, and G Xing-Bo, and F Lin-Chun
December 1996, European journal of clinical investigation,
Copied contents to your clipboard!